Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Plos One|June 1, 2012
Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastomaGlen J Weiss, Winnie S Liang, Tyler Izatt, et al.
Cancer Research|March 5, 2009
Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancerWennuan Liu, Jishan Sun, Ge Li, et al.
BMC Medical Genomics|October 21, 2017
A method to reduce ancestry related germline false positives in tumor only somatic variant callingRebecca F Halperin, John D Carpten, Zarko Manojlovic, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|January 17, 2015
An integrated framework for reporting clinically relevant biomarkers from paired tumor/normal genomic and transcriptomic sequencing data in support of clinical trials in personalized medicineSara Nasser, Ahmet A Kurdolgu, Tyler Izatt, et al.
Blood|April 14, 2012
Clonal competition with alternating dominance in multiple myelomaJonathan J Keats, Marta Chesi, Jan B Egan, et al.
Genome Research|December 15, 2010
Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumorsChristiane M Robbins, Waibov A Tembe, Angela Baker, et al.
Plos One|November 9, 2013
A pilot study using next-generation sequencing in advanced cancers: feasibility and challengesGlen J Weiss, Winnie S Liang, Michael J Demeure, et al.
Genome Biology|January 14, 2017
Identifying aggressive prostate cancer foci using a DNA methylation classifierKamilla Mundbjerg, Sameer Chopra, Mehrdad Alemozaffar, et al.
Mutation Research|July 23, 2003
Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association studySiqun L Zheng, Josyf C Mychaleckyj, Gregory A Hawkins, et al.
The Prostate|August 22, 2006
A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS studyS Lilly Zheng, Wennuan Liu, Fredrik Wiklund, et al.
Pageof 12